Sign in

CIK 0001812364 · Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. 8-K Event Regulation FD disclosure · Other events
  2. 4 Open-market sale President, R&D sold 21,581 shares at an average $7.72 ($166,677)
  3. 4 Open-market sale See remarks sold 13,038 shares at an average $7.71 ($100,473)
  4. 4 Open-market sale Chief Financial Officer sold 15,515 shares at an average $7.71 ($119,631)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale President and CEO sold 43,168 shares at $7.82 ($337,574)
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations · Executive or director change · Regulation FD disclosure
  17. 4 Open-market sale President and CEO sold 62,073 shares at $7.00 ($434,511)
  18. 4 Open-market sale See remarks sold 40,529 shares at an average $7.40 ($299,949)
  19. 4 Open-market sale Chief Financial Officer sold 21,664 shares at $7.29 ($157,931)
  20. 4 Open-market sale President, R&D sold 30,897 shares at $7.29 ($225,239)

Page 5 of 28 · 556 filings